Anti-HADHA antibody [EPR17940]
- 20ul selling size
- RabMAb
- Recombinant
- KO Validated
- What is this?
Be the first to review this product! Submit a review
|
(17 Publications)
Rabbit Recombinant Monoclonal HADHA antibody. Suitable for IP, WB, ICC/IF, Flow Cyt (Intra), IHC-P and reacts with Human, Mouse, Rat samples. Cited in 17 publications.
View Alternative Names
HADH, HADHA, 78 kDa gastrin-binding protein, Monolysocardiolipin acyltransferase, TP-alpha, MLCL AT
- ICC/IF
Supplier Data
Immunocytochemistry/ Immunofluorescence - Anti-HADHA antibody [EPR17940] (AB203114)
Immunofluorescent analysis of 4% paraformaldehyde-fixed, 0.1% Triton X-100 permeabilized Jurkat (Human T cell leukemia cells from peripheral blood) cells labeling HADHA with ab203114 at 1/250 dilution, followed by Goat anti-rabbit IgG (Alexa Fluor® 488) (ab150077) secondary antibody at 1/1000 dilution (green). Confocal image showing cytoplasmic staining on Jurkat cell line.
The nuclear counter stain is DAPI (blue). COX IV is detected with ab33985 (anti-COX IV Mitochondrial Marker mouse mAb) at 1/1000 dilution and ab150120 (AlexaFluor®594 Goat anti-Mouse secondary) at 1/1000 dilution (red).
The negative controls are as follows :
-ve control 1 : ab203114 at 1/250 dilution followed by ab150120 (AlexaFluor®594 Goat anti-Mouse secondary) at 1/1000 dilution.
-ve control 2 : ab33985 (anti-COX IV Mitochondrial Marker mouse mAb) at 1/1000 dilution followed by ab150077 (Alexa Fluor®488 Goat Anti-Rabbit IgG H&L) at 1/1000 dilution.
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-HADHA antibody [EPR17940] (AB203114)
Immunohistochemical analysis of paraffin-embedded Human cervix carcinoma tissue labeling HADHA with ab203114 at 1/50 dilution, followed by Goat Anti-Rabbit IgG H&L (HRP) (ab97051) at 1/500 dilution. Cytoplasmic staining on Human cervix carcinoma tissue is observed. Counter stained with Hematoxylin.
Secondary antibody only control : Used PBS instead of primary antibody, secondary antibody is Goat Anti-Rabbit IgG H&L (HRP) (ab97051) at 1/500 dilution.
Perform heat mediated antigen retrieval with Tris/EDTA buffer pH 9.0 before commencing with IHC staining protocol.
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-HADHA antibody [EPR17940] (AB203114)
Immunohistochemical analysis of paraffin-embedded Human tonsil tissue labeling HADHA with ab203114 at 1/50 dilution, followed by Goat Anti-Rabbit IgG H&L (HRP) (ab97051) at 1/500 dilution. Cytoplasmic staining on Human tonsil tissue is observed. Counter stained with Hematoxylin.
Secondary antibody only control : Used PBS instead of primary antibody, secondary antibody is Goat Anti-Rabbit IgG H&L (HRP) (ab97051) at 1/500 dilution.
Perform heat mediated antigen retrieval with Tris/EDTA buffer pH 9.0 before commencing with IHC staining protocol.
- ICC/IF
Supplier Data
Immunocytochemistry/ Immunofluorescence - Anti-HADHA antibody [EPR17940] (AB203114)
Immunofluorescent analysis of 4% paraformaldehyde-fixed, 0.1% Triton X-100 permeabilized HeLa (Human epithelial cells from cervix adenocarcinoma) cells labeling HADHA with ab203114 at 1/250 dilution, followed by Goat anti-rabbit IgG (Alexa Fluor® 488) (ab150077) secondary antibody at 1/1000 dilution (green). Confocal image showing cytoplasmic staining on HeLa cell line.
The nuclear counter stain is DAPI (blue). COX IV is detected with ab33985 (anti-COX IV Mitochondrial Marker mouse mAb) at 1/1000 dilution and ab150120 (AlexaFluor®594 Goat anti-Mouse secondary) at 1/1000 dilution (red).
The negative controls are as follows :
-ve control 1 : ab203114 at 1/250 dilution followed by ab150120 (AlexaFluor®594 Goat anti-Mouse secondary) at 1/1000 dilution.
-ve control 2 : ab33985 (anti-COX IV Mitochondrial Marker mouse mAb) at 1/1000 dilution followed by ab150077 (Alexa Fluor®488 Goat Anti-Rabbit IgG H&L) at 1/1000 dilution.
- Flow Cyt (Intra)
Supplier Data
Flow Cytometry (Intracellular) - Anti-HADHA antibody [EPR17940] (AB203114)
Intracellular flow cytometric analysis of 4% paraformaldehyde-fixed HeLa (Human epithelial cells from cervix adenocarcinoma) cells labeling HADHA with ab203114 at 1/100 dilution (red) compared with a rabbit monoclonal IgG isotype control (ab172730; black) and an unlabelled control (cells without incubation with primary antibody and secondary antibody; blue). Goat anti rabbit IgG (FITC) at 1/500 dilution was used as the secondary antibody.
- ICC/IF
Lab
Immunocytochemistry/ Immunofluorescence - Anti-HADHA antibody [EPR17940] (AB203114)
ab203114 staining HADHA in wild-type HAP1 cells (top panel) and HADHA knockout HAP1 cells (bottom panel). The cells were fixed with 100% methanol for 5 minutes, permeabilized with 0.1% Triton X-100 for 5 minutes and then blocked with 1% BSA/10% normal goat serum/0.3M glycine in 0.1% PBS-Tween for 1 hour. The cells were then incubated with ab203114 at 1μg/ml concentration dilution and ab195889 at 1/250 dilution (shown in pseudo colour red) overnight at +4°C, followed by a further incubation at room temperature for 1 hour with Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) preadsorbed (ab150081) secondary antibody at 2 μg/ml (shown in green). Nuclear DNA was labelled in blue with DAPI.
Image was taken with a confocal microscope (Leica-Microsystems, TCS SP8).
- IP
Supplier Data
Immunoprecipitation - Anti-HADHA antibody [EPR17940] (AB203114)
HADHA was immunoprecipitated from 1mg of HeLa (Human epithelial cells from cervix adenocarcinoma) whole cell lysate with ab203114 at 1/400 dilution. Western blot was performed from the immunoprecipitate using ab203114 at 1/1000 dilution. Anti-Rabbit IgG (HRP), specific to the non-reduced form of IgG, was used as secondary antibody at 1/1500 dilution.
Lane 1 : HeLa whole cell lysate 10ug (Input). Lane 2 : ab203114 IP in HeLa whole cell lysate. Lane 3 : Rabbit monoclonal IgG (ab172730) instead of ab203114 in HeLa whole cell lysate.
Blocking and dilution buffer and concentration : 5% NFDM/TBST.
Exposure time : 3 seconds.
All lanes:
Immunoprecipitation - Anti-HADHA antibody [EPR17940] (ab203114)
Predicted band size: 83 kDa
false
- WB
Lab
Western blot - Anti-HADHA antibody [EPR17940] (AB203114)
Lanes 1 - 4 : Merged signal (red and green). Green - ab203114 observed at 82 kDa. Red - loading control, ab8245, observed at 37 kDa.
ab203114 was shown to specifically react with HADHA when HADHA knockout samples were used. Wild-type and HADHA knockout samples were subjected to SDS-PAGE. ab203114 and ab8245 (loading control to GAPDH) were diluted at 1/1000 and 1/10 000 respectively and incubated overnight at 4°C. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preadsorbed (ab216776) secondary antibodies at 1/10000 dilution for 1 h at room temperature before imaging.
All lanes:
Western blot - Anti-HADHA antibody [EPR17940] (ab203114) at 1/1000 dilution
Lane 1:
Wild-type HAP1 cell lysate at 20 µg
Lane 2:
HADHA knockout HAP1 cell lysate at 20 µg
Lane 3:
HEK293 cell lysate at 20 µg
Lane 4:
HepG2 cell lysate at 20 µg
Predicted band size: 83 kDa
false
- WB
Supplier Data
Western blot - Anti-HADHA antibody [EPR17940] (AB203114)
Blocking/Dilution buffer : 5% NFDM/TBST.
All lanes:
Western blot - Anti-HADHA antibody [EPR17940] (ab203114) at 1/1000 dilution
Lane 1:
Human fetal liver lysate at 10 µg
Lane 2:
Human fetal kidney lysate at 10 µg
Secondary
All lanes:
Anti-Rabbit IgG (HRP), specific to the non-reduced form of IgG at 1/50000 dilution
Predicted band size: 83 kDa
Observed band size: 74 kDa
false
Exposure time: 30s
- WB
Supplier Data
Western blot - Anti-HADHA antibody [EPR17940] (AB203114)
Blocking/Dilution buffer : 5% NFDM/TBST.
All lanes:
Western blot - Anti-HADHA antibody [EPR17940] (ab203114) at 1/10000 dilution
Lane 1:
HeLa (Human epithelial cells from cervix adenocarcinoma) cell lysate at 20 µg
Lane 2:
HEK-293 (Human epithelial cells from embryonic kidney) cell lysate at 20 µg
Lane 3:
HepG2 (Human liver hepatocellular carcinoma) cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/50000 dilution
Predicted band size: 83 kDa
Observed band size: 74 kDa
false
Exposure time: 3min
- WB
Lab
Western blot - Anti-HADHA antibody [EPR17940] (AB203114)
Lanes 1-4 : Merged signal (red and green). Green - ab203114 observed at 82 kDa. Red - loading control ab8245 observed at 37 kDa.
ab203114 Anti-HADHA antibody [EPR17940] was shown to specifically react with HADHA in wild-type HEK-293T cells. Loss of signal was observed when knockout cell line ab266274 (knockout cell lysate ab257464) was used. Wild-type and HADHA knockout samples were subjected to SDS-PAGE. ab203114 and Anti-GAPDH antibody [6C5] - Loading Control (ab8245) were incubated overnight at 4°C at 1 in 1000 and 1 in 20000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preadsorbed (ab216776) secondary antibodies at 1 in 20000 dilution for 1 hour at room temperature before imaging.
All lanes:
Western blot - Anti-HADHA antibody [EPR17940] (ab203114) at 1/1000 dilution
Lane 1:
Wild-type HEK-293T cell lysate at 20 µg
Lane 2:
HADHA knockout HEK-293T cell lysate at 20 µg
Lane 2:
Western blot - Human HADHA knockout HEK-293T cell line (<a href='/en-us/products/cell-lines/human-hadha-knockout-hek-293t-cell-line-ab266274'>ab266274</a>)
Lane 3:
HepG2 cell lysate at 20 µg
Lane 4:
SH-SY5Y cell lysate at 20 µg
Predicted band size: 83 kDa
Observed band size: 82 kDa
false
- WB
Supplier Data
Western blot - Anti-HADHA antibody [EPR17940] (AB203114)
Blocking/Dilution buffer : 5% NFDM/TBST.
All lanes:
Western blot - Anti-HADHA antibody [EPR17940] (ab203114) at 1/1000 dilution
All lanes:
Jurkat (Human T cell leukemia cells from peripheral blood) cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/50000 dilution
Predicted band size: 83 kDa
Observed band size: 74 kDa
false
Exposure time: 3min
- WB
Supplier Data
Western blot - Anti-HADHA antibody [EPR17940] (AB203114)
Blocking/Dilution buffer : 5% NFDM/TBST.
All lanes:
Western blot - Anti-HADHA antibody [EPR17940] (ab203114) at 1/2000 dilution
Lane 1:
Mouse heart lysate at 10 µg
Lane 2:
Mouse kidney lysate at 10 µg
Lane 3:
Rat heart lysate at 10 µg
Lane 4:
Rat kidney lysate at 10 µg
Lane 5:
C6 (Rat glial tumor cells) cell lysate at 10 µg
Lane 6:
RAW 264.7 (Mouse macrophage cells transformed with Abelson murine leukemia virus) cell lysate at 10 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/50000 dilution
Predicted band size: 83 kDa
Observed band size: 74 kDa
false
Exposure time: 15s
- WB
CiteAb
Western blot - Anti-HADHA antibody [EPR17940] (AB203114)
HADHA western blot using anti-HADHA antibody [EPR17940] ab203114. Publication image and figure legend from Chen, J., Zhuang, Y., et al., 2019, Int J Mol Sci, PubMed 31618976.
ab203114 was used in this publication in western blot. This may not be the same as the application(s) guaranteed by Abcam. For a full list of applications guaranteed by Abcam for ab203114 please see the product overview.
Expression levels of proteins in fatty acid β-oxidation, fatty acid synthesis, and triglyceride synthesis pathways. Immunoblot analysis of indicated proteins in the liver of P2 Pparb/dfl/fl and FSP1cre-Pparb/d-/- mice. Representative blots from 7 mice (biological replicates) for each genotype and the results of the 6-7 mice (biological replicates) are shown in bar graphs. Two-tailed Mann-Whitney test with values shown as mean ± s.e.m. * p < 0.05, ** p < 0.01; FSP1cre-Pparb/d-/- vs. Pparb/dfl/fl controls. (a) HADHA. β-actin was used as loading and transfer control. (b) Phospho-ACLY and ACLY. β-tubulin was used as loading and transfer control. (c) Phospho-ACC and ACC. β-tubulin was used as loading and transfer control. (d) GPD2. β-actin was used as loading and transfer control. The full size original western blots are shown in Figure SM2.
false
Related conjugates and formulations (10)
-
Anti-HADHA antibody [EPR17940] - BSA and Azide free
-
660 APC
APC Anti-HADHA antibody [EPR17940]
-
519 Alexa Fluor® 488
Alexa Fluor® 488 Anti-HADHA antibody [EPR17940]
-
565 Alexa Fluor® 555
Alexa Fluor® 555 Anti-HADHA antibody [EPR17940]
-
603 Alexa Fluor® 568
Alexa Fluor® 568 Anti-HADHA antibody [EPR17940]
-
617 Alexa Fluor® 594
Alexa Fluor® 594 Anti-HADHA antibody [EPR17940]
-
665 Alexa Fluor® 647
Alexa Fluor® 647 Anti-HADHA antibody [EPR17940]
-
775 Alexa Fluor® 750
Alexa Fluor® 750 Anti-HADHA antibody [EPR17940]
-
HRP Anti-HADHA antibody [EPR17940]
-
578 PE
PE Anti-HADHA antibody [EPR17940]
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
HADHA is a part of the mitochondrial trifunctional protein complex which consists of four alpha and four beta subunits. It facilitates the hydration of enoyl-CoA to 3-hydroxyacyl-CoA and the subsequent dehydrogenation to 3-ketoacyl-CoA. This enzyme works closely with its partner the HADHB protein to carry out these reactions efficiently. These functions are important for energy production as they are steps in the breakdown of fatty acids necessary for ATP generation.
Pathways
HADHA participates in the mitochondrial beta-oxidation pathway an essential pathway for energy production from fats. Alongside HADHB it catalyzes key reactions that allow the progressive shortening of fatty acid chains which further feeds into the citric acid cycle. This pathway links HADHA not only to HADHB but also to other enzymes involved in lipid metabolism and energy homeostasis including medium-chain specific acyl-CoA dehydrogenase (MCAD) reflecting its role in comprehensive metabolic networks.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (17)
Recent publications for all applications. Explore the full list and refine your search
Journal of nanobiotechnology 23:485 PubMed40616128
2025
Applications
Unspecified application
Species
Unspecified reactive species
Scientific reports 15:7768 PubMed40044936
2025
Applications
Unspecified application
Species
Unspecified reactive species
Advanced science (Weinheim, Baden-Wurttemberg, Germany) 11:e2405147 PubMed39488787
2024
Applications
Unspecified application
Species
Unspecified reactive species
Acta biochimica et biophysica Sinica 57:378-388 PubMed39327932
2024
Applications
Unspecified application
Species
Unspecified reactive species
EMBO molecular medicine 16:2450-2484 PubMed39271959
2024
Applications
Unspecified application
Species
Unspecified reactive species
Cell stem cell 31:378-397.e12 PubMed38402617
2024
Applications
Unspecified application
Species
Unspecified reactive species
The Journal of biological chemistry 299:105210 PubMed37660922
2023
Applications
Unspecified application
Species
Unspecified reactive species
Molecular biology reports 50:961-970 PubMed36376538
2022
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in physiology 13:873465 PubMed36082219
2022
Applications
Unspecified application
Species
Unspecified reactive species
Journal of cancer prevention 26:32-40 PubMed33842404
2021
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com